Issuances of Securities (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Jan. 06, 2021
Jun. 25, 2021
May 31, 2021
Apr. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Common stock shares cancellations           22,381
Increasing additional paid-in capital           $ 22
Fair value of debt           866,482
Loss on debt settlement           316,915
Unrecognized compensation cost         $ 27,017,200  
Loss on settlement of debt         (434,570) (316,521)
Proceeds from issuance of cost         479,802 1,130,696
Related party advances         245,500 251,730
Stock based compensation expense         26,861,097 $ 12,722,805
Common stock, shares issued for service renderred, amount         $ 867,368  
January 1, 2021 [Member]            
Restricted stock units, vesting         9,960,000  
Stock based compensation expense         $ 43,121  
Fair value of restricted stock units         $ 7,071,600  
Unvested restricted stock units         9,960,000  
Mr. Heaton [Member]            
Restricted stock units, vesting         200,000  
Restricted stock units granted     500,000   500,000 500,000
Stock based compensation expense         $ 220,000  
Fair value of restricted stock units         $ 200,000  
Consultant [Member]            
Common stock shares issued during the period         6,252  
Common stock, shares issued for service renderred, shares         40,000 250,000
Common stock, shares issued for service renderred, amount         $ 32,800 $ 153,750
Legal Counsels [Member]            
Fair value of vesting         $ 26,425  
Common stock, shares issued for service renderred, shares         325,000  
Restricted stock units, vesting         35,000  
Restricted stock units granted         100,000  
Stock based compensation expense         $ 230,750  
Litigation Settlement [Member]            
Common stock shares issued during the period         300,000  
Fair value of common stock         $ 312,000  
Convertible Notes Payable [Member]            
Common stock shares issued during the period         1,085,135  
Accrued interest         $ 590,467  
Convertible Notes Payable 1 [Member]            
Common stock shares issued during the period         1,353,111  
Accrued interest         $ 676,555  
Mr. Beplate [Member]            
Common stock, shares issued for service renderred, shares         2,000,000  
Stock based compensation expense $ 26,127,300       $ 2,180,000  
Officers And Directors [Member]            
Common stock, shares issued for service renderred, shares         32,490,000  
Stock based compensation expense         $ 24,467,597  
Chief Executive Officers [Member]            
Common stock, shares issued for service renderred, shares         50,000 125,000
Restricted stock units, vesting         50,000  
Common stock, shares issued for service renderred, amount           $ 100,625
Medical advisor [Member]            
Common stock, shares issued for service renderred, shares           50,000
Common stock, shares issued for service renderred, amount           $ 47,500
Non Affiliated Investor [Member] | Private Placement [Member]            
Common stock shares issued during the period         370,455 2,000,500
Proceeds from issuance of cost         $ 326,000 $ 1,130,696
Officers [Member]            
Common stock, shares issued for service renderred, shares         85,000  
Common stock, shares issued for service renderred, amount         $ 69,700  
Affiliated Investor [Member] | Private Placement [Member]            
Proceeds from issuance of cost         $ 100,000  
Common stock, shares issued for service renderred, shares         125,000  
Triton Funds LP [Member]            
Proceeds from issuance of cost         $ 53,802  
Common stock, shares issued for service renderred, shares         61,000  
Common stock purchase agreement description   Triton up to $6,000,000 of common stock. Subject to the terms and conditions of the Purchase Agreement, Triton agreed to purchase from the Company $4,000,000 in value of common shares at closing, based on a purchase price determined by dividing $200,000,000 by the number of outstanding shares of Common Stock, as reported by the Company on its most recently filed Form 10-K or 10-Q.        
Additional shares of common stock   $ 2,000,000        
Share Issuances [Member]            
Common stock shares issued during the period         1,013,085  
Accrued liabilities related party         $ 561,548  
Loss on settlement of debt         306,220  
Proceeds from issuance of cost         $ 867,368  
Share Issuances 2021 [Member]            
Common stock shares issued during the period         25,000  
Loss on settlement of debt         $ 6,750  
Proceeds from issuance of cost         26,750  
Related party advances         $ 20,000  
Share Issuances 1 [Member]            
Common stock shares issued during the period         380,000  
Loss on settlement of debt         $ 121,600  
Accrued compensation         190,000  
Fair value of common stock         311,600  
Consultant Agreement [Member]            
Fair value of common stock         $ 111,000  
Common stock, shares issued for service renderred, shares         100,000  
Restricted Stock Units [Member]            
Restricted stock units granted         11,500,000  
Restricted stock units, description       RSU agreement with a service provider granting 750,000 RSU’s on the date of the agreement and will grant an additional 750,000 RSU’s, upon the receipt by the Company of an FDA Class III PMA. The 750,000 RSU’s had a grant date fair value of $664,875. The amendment accelerated the vesting and immediately settled his remaining RSU’s by issuing 21,970,000 shares of common stock. Per ASC 718-20-35, the change in vesting conditions resulted in a modification of the stock-based compensation awards. The modification is considered a Type III modification as described in ASC 718-20-55 and resulted in recording $23,947,300 of stock-based compensation expense which was the fair value of the shares on the date of the modification.  
Common Stock [Member]            
Common stock shares cancellations         117,647  
Increasing additional paid-in capital         $ 117  
Common stock shares issued during the period         162,662 1,058,634